HAPPY EASTER! 50% Off Premium Subscription Claim Offer ⏰ 0d 00h 00m 00s
AI Analysis AI Analysis of IRMD
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

iRadimed Corporation stock price ended at $51.96 on Wednesday, after losing 0%
(Updated on Apr 16, 2025)

Sell candidate since Apr 15, 2025

No changes to the price of iRadimed Corporation stock on the last trading day (Wednesday, 16th Apr 2025). During the last trading day the stock fluctuated 2.82% from a day low at $50.67 to a day high of $52.10. The price has fallen in 6 of the last 10 days and is down by -3.06% for this period.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.28% during the next 3 months and, with a 90% probability hold a price between $39.35 and $44.39 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

IRMD Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, April 08, 2025, and so far it has risen 6.76%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The iRadimed Corporation stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $52.26. On a fall, the stock will find some support from the short-term average at $51.40. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The stock had a Golden Star Signal on Friday, June 21, 2024 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Friday, June 21, 2024 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for iRadimed Corporation stock

iRadimed Corporation finds support from accumulated volume at $51.76 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $1.43 between high and low, or 2.82%. For the last week the stock has had daily average volatility of 5.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IRMD) For The Upcoming Trading Day Of Thursday 17th

For the upcoming trading day on Thursday, 17th we expect iRadimed Corporation to open at $51.58, and during the day (based on 14 day Average True Range), to move between $49.82 and $54.10, which gives a possible trading interval of +/-$2.14 (+/-4.12%) up or down from last closing price. If iRadimed Corporation takes out the full calculated possible swing range there will be an estimated 8.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $51.76 (0.38%) than the resistance at $52.84 (1.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is iRadimed Corporation stock A Buy?

iRadimed Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.274 Sell Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on April 17, 2025 - $51.58 ( 0.738%).

IRMD Performance

Trading levels for IRMD

Fibonacci Support & Resistance Levels

Level Price
R3 53.01 2.01%
R2 52.46 0.96%
R1 52.12 0.314%
Price 51.96
S1 51.03 -1.79%
S2 50.69 -2.44%
S3 50.15 -3.49%

Accumulated Volume Support & Resistance Levels

Level Price
R3 60.48 16.40%
R2 55.41 6.63%
R1 52.84 1.69%
Price 51.96
S1 51.76 -0.385%
S2 49.92 -3.93%
S3 49.37 -4.98%

IRMD Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 06, 2025 Feb 24, 2025 Mar 05, 2025 $0.170 0.320%
2 Oct 31, 2024 Nov 15, 2024 Nov 25, 2024 $0.150 0.281%
3 Aug 01, 2024 Aug 20, 2024 Aug 30, 2024 $0.150 0.319%
4 May 02, 2024 May 17, 2024 May 30, 2024 $0.150 0.356%
5 Dec 12, 2023 Dec 21, 2023 Jan 12, 2024 $0.630 1.39%

FAQ

What is the symbol for iRadimed Corporation Stock and on which exchange is it traded?
The symbol for iRadimed Corporation is IRMD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell iRadimed Corporation Stock?
iRadimed Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy iRadimed Corporation Stock?
iRadimed Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy iRadimed Corporation Stock.

What's the current price of iRadimed Corporation Stock?
As of the end of day on the Apr 16, 2025, the price of an iRadimed Corporation (IRMD) share was $51.96.

What is the 52-week high and low for iRadimed Corporation Stock?
The 52-week high for iRadimed Corporation Stock is $63.25 and the 52-week low is $40.18.

What is the market capitalization of iRadimed Corporation Stock?
As of the Apr 16, 2025, the market capitalization of iRadimed Corporation is 674.282M.

When is the next earnings date for iRadimed Corporation?
The upcoming earnings date for iRadimed Corporation is May 01, 2025.
Click to get the best stock tips daily for free!
ABOUT IRADIMED CORPORATION
iRadimed
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote dis...
GOLDEN STAR
Ticker Change Signal Date
I
ISTB
$48.08
0.291% Apr 14
B
BSCS
$20.24
0.395% Apr 14
BAH
$108.78
2.31% Apr 11
K
$82.14
0.183% Apr 10
ESGR
$332.23
0.226% Apr 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE